000 01733 a2200481 4500
005 20250517144706.0
264 0 _c20180430
008 201804s 0 0 eng d
022 _a1346-8138
024 7 _a10.1111/1346-8138.13827
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaniguchi, Takashi
245 0 0 _aCritical contribution of the interleukin-6/signal transducer and activator of transcription 3 axis to vasculopathy associated with systemic sclerosis.
_h[electronic resource]
260 _bThe Journal of dermatology
_cAug 2017
300 _a967-971 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Humanized
_xpharmacology
650 0 4 _aCapillaries
_xdiagnostic imaging
650 0 4 _aDermoscopy
650 0 4 _aEndothelial Cells
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNails
_xblood supply
650 0 4 _aPilot Projects
650 0 4 _aProto-Oncogene Protein c-fli-1
650 0 4 _aReceptors, Interleukin-6
_xantagonists & inhibitors
650 0 4 _aSTAT3 Transcription Factor
_xmetabolism
650 0 4 _aScleroderma, Systemic
_xdrug therapy
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSkin
_xdrug effects
650 0 4 _aVascular Diseases
_xdrug therapy
700 1 _aAsano, Yoshihide
700 1 _aFukasawa, Takemichi
700 1 _aYoshizaki, Ayumi
700 1 _aSato, Shinichi
773 0 _tThe Journal of dermatology
_gvol. 44
_gno. 8
_gp. 967-971
856 4 0 _uhttps://doi.org/10.1111/1346-8138.13827
_zAvailable from publisher's website
999 _c27015281
_d27015281